000 | 01994 a2200481 4500 | ||
---|---|---|---|
005 | 20250517033357.0 | ||
264 | 0 | _c20151125 | |
008 | 201511s 0 0 eng d | ||
022 | _a1530-6860 | ||
024 | 7 |
_a10.1096/fj.15-271635 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRusskamp, Norman F | |
245 | 0 | 0 |
_aExperimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin. _h[electronic resource] |
260 |
_bFASEB journal : official publication of the Federation of American Societies for Experimental Biology _cSep 2015 |
||
300 |
_a3762-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcute Lung Injury _xdrug therapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCCR5 Receptor Antagonists _xpharmacology |
650 | 0 | 4 | _aComplement Activation |
650 | 0 | 4 |
_aComplement C3a _xgenetics |
650 | 0 | 4 |
_aComplement C5a, des-Arginine _xgenetics |
650 | 0 | 4 |
_aCyclohexanes _xpharmacology |
650 | 0 | 4 |
_aLeukocytes _xmetabolism |
650 | 0 | 4 |
_aMAP Kinase Kinase 1 _xgenetics |
650 | 0 | 4 |
_aMAP Kinase Kinase 2 _xgenetics |
650 | 0 | 4 | _aMaraviroc |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xgenetics |
650 | 0 | 4 |
_aPulmonary Alveoli _xmetabolism |
650 | 0 | 4 |
_aReceptor, Anaphylatoxin C5a _xgenetics |
650 | 0 | 4 |
_aReceptors, CCR5 _xgenetics |
650 | 0 | 4 |
_aTriazoles _xpharmacology |
700 | 1 | _aRuemmler, Robert | |
700 | 1 | _aRoewe, Julian | |
700 | 1 | _aMoore, Bethany B | |
700 | 1 | _aWard, Peter A | |
700 | 1 | _aBosmann, Markus | |
773 | 0 |
_tFASEB journal : official publication of the Federation of American Societies for Experimental Biology _gvol. 29 _gno. 9 _gp. 3762-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1096/fj.15-271635 _zAvailable from publisher's website |
999 |
_c24925061 _d24925061 |